Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Hepatitis C virus p7 protein is a 63-amino acid membrane protein located between the E2 envelope protein and NS2 protease in the HCV polyprotein[5][7]. It features two transmembrane alpha helices connected by a conserved, cytosolic loop, and localizes mainly to the endoplasmic reticulum but can also be found near mitochondria and at the plasma membrane[1][4]. p7 oligomerizes to form hexameric or heptameric ion channels that selectively conduct cations and possibly protons, serving a crucial role in dissipating the acidic environment of cellular organelles required for efficient viral assembly, maturation, and secretion of infectious virions[1][2][4][7]. p7’s ion channel function is distinct from host ion channels; its activity can be blocked by small-molecule inhibitors such as amantadine and rimantadine, although genotype-dependent differences affect drug susceptibility[2][3]. Additionally, p7 participates in virus-specific assembly processes involving direct interactions with other HCV proteins, such as NS2, E1, E2, core, and NS5A, independent of its ion channel function[1][4]. The essential role of p7 in the HCV life cycle, alongside the feasibility of small-molecule inhibition, establishes it as a validated antiviral drug target under continued investigation. If more structured data about its amino acid sequence, 3D structure, or experimental drug candidates is needed, molecular databases (e.g., RCSB for 2M6X[2]) can provide direct access to such entries.
Blockade of p7 ion channel pore (amantadine, rimantadine); Prevention of p7 oligomerization or interactions with viral/host factors; Disruption of pH gradient modulation within host cell organelles[2][3][6]
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatitis C virus p7 protein (p7).